ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo

Spine (Phila Pa 1976). 2004 Dec 1;29(23):2603-11. doi: 10.1097/01.brs.0000146103.94600.85.

Abstract

Study design: Experiments using both in vitro tissue culture and in vivo rabbit methods were used to study the effect of Lim Mineralization Protein-1 (LMP-1) on intervertebral disc (IVD) cell production of proteoglycans and bone morphogenetic proteins (BMPs).

Objectives: To determine the effect of LMP-1 overexpression in IVD cells on the production of proteoglycans and BMPs both in vitro and in vivo and to show that LMP-1 mediates the control of proteoglycan production through its action on BMPs.

Summary of background data: Because BMPs are known to increase proteoglycan synthesis and LMP-1 is known to upregulate BMPs in certain cells, it was hypothesized that LMP-1 may increase proteoglycan production in IVD cells.

Methods: DMMB, real-time polymerase chain reaction, and ELISA methods were used to quantitate proteoglycan, mRNA, and protein levels, respectively. Noggin was used to block the effect of the adenovirus carrying LMP-1 (AdLMP-1) on proteoglycan synthesis. In vivo experiments using intradiscal AdLMP-1 injection were performed with New Zealand White rabbits. Three weeks later, the mRNA levels of LMP-1, aggrecan, BMP-2, and BMP-7 were measured.

Results: In vitro experiments revealed that the sulfated glycosaminoglycan (sGAG) and aggrecan mRNA levels were significantly increased with AdLMP-1 treatment. Similarly, BMP-2 and BMP-7 mRNA and protein levels increased significantly, but BMP-4 and BMP-6 levels were unchanged. Noggin blocked the upregulation of proteoglycan by AdLMP-1. In vivo discs injected with AdLMP-1 had significantly elevated levels of LMP-1, BMP-2, and BMP-7 mRNA.

Conclusions: LMP-1 overexpression increases disc cell production of proteoglycan, BMP-2, and BMP-7. LMP-1 mediates the control of proteoglycan production through its action on BMP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Adenoviridae / genetics
  • Aggrecans
  • Animals
  • Awards and Prizes*
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / metabolism*
  • Cytoskeletal Proteins
  • Disease Models, Animal
  • Extracellular Matrix Proteins / genetics
  • Extracellular Matrix Proteins / metabolism
  • Genetic Vectors
  • Glycosaminoglycans / genetics
  • Glycosaminoglycans / metabolism
  • Humans
  • Intervertebral Disc / drug effects*
  • Intervertebral Disc / metabolism
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Intracellular Signaling Peptides and Proteins / pharmacology*
  • LIM Domain Proteins
  • Lectins, C-Type / genetics
  • Lectins, C-Type / metabolism
  • Orthopedics*
  • Proteoglycans / genetics
  • Proteoglycans / metabolism*
  • RNA, Messenger / metabolism
  • Rabbits
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Up-Regulation / drug effects

Substances

  • Acan protein, rat
  • Adaptor Proteins, Signal Transducing
  • Aggrecans
  • BMP2 protein, human
  • BMP7 protein, human
  • Bmp2 protein, rat
  • Bmp7 protein, rat
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Cytoskeletal Proteins
  • Extracellular Matrix Proteins
  • Glycosaminoglycans
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Lectins, C-Type
  • PDLIM7 protein, human
  • Proteoglycans
  • RNA, Messenger
  • Transforming Growth Factor beta
  • A73025